Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference
October 30 2024 - 4:15PM
Prenetics, (NASDAQ: PRE) a leading health sciences company,
announced today that management will participate in the Sidoti
Virtual Micro Cap Conference being held on November 13-14, 2024.
Prenetics’ Chief Executive Officer Danny Yeung
and Chief Financial Officer Stephen Lo will present virtually on
Wednesday, November 13th at 8:30 a.m. ET. A link to the webcast can
be accessed through the investor section of the Company’s website
at https://ir.prenetics.com/.
Additionally, management will be available for
one-on-one investor meetings on Wednesday, November 13th. To
schedule a one-on-one meeting with Prenetics’ management, please
contact your Sidoti representative or reach out to investor
relations at PRE@mzgroup.us.
About PreneticsPrenetics
(NASDAQ:PRE), a leading health sciences company, is dedicated to
advancing consumer and clinical health. Our consumer initiative is
led by IM8, a new health and wellness brand and Europa, one of the
largest sports distribution companies in the USA. Our clinical
division is led by Insighta, our $200 million venture focused on
multi-cancer early detection technologies. This is followed by ACT
Genomics, which has achieved FDA clearance for comprehensive
genomic profiling of solid tumors, and CircleDNA, which uses NGS to
offer comprehensive DNA tests. Each of Prenetics’ units
synergistically enhances our global impact on health, embodying our
commitment to ‘enhancing life through science’. To learn more about
Prenetics, please visit www.prenetics.com.
Investor Relations
Contact:investors@prenetics.comPRE@mzgroup.us
Angela CheungInvestor Relations / Corporate
FinancePrenetics Global Limitedangela.hm.cheung@prenetics.com
Prenetics Global (NASDAQ:PRE)
Historical Stock Chart
From Nov 2024 to Dec 2024
Prenetics Global (NASDAQ:PRE)
Historical Stock Chart
From Dec 2023 to Dec 2024